Search by Drug Name or NDC
NDC 63739-0067-02 Mucus Relief 600 mg/1 Details
Mucus Relief 600 mg/1
Mucus Relief is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by McKesson Corporation dba SKY Packaging. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 63739-0067-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 63739-0067 |
---|---|
Product ID | 63739-067_b8593c77-a6de-4ace-b373-565df95f158d |
Associated GPIs | 43200010007420 |
GCN Sequence Number | 071885 |
GCN Sequence Number Description | guaifenesin TAB ER 12H 600 MG ORAL |
HIC3 | B3J |
HIC3 Description | EXPECTORANTS |
GCN | 35905 |
HICL Sequence Number | 000271 |
HICL Sequence Number Description | GUAIFENESIN |
Brand/Generic | Generic |
Proprietary Name | Mucus Relief |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 600 |
Active Ingredient Units | mg/1 |
Substance Name | GUAIFENESIN |
Labeler Name | McKesson Corporation dba SKY Packaging |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA209215 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 63739-0067-02 (63739006702)
NDC Package Code | 63739-067-02 |
---|---|
Billing NDC | 63739006702 |
Package | 30 BLISTER PACK in 1 BOX (63739-067-02) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Marketing Start Date | 2021-10-20 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.32501 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | MUCUS RELIEF ER 600 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL 69b61f05-8f0b-420f-b4ef-df933b70eebc Details
USE(S)
ASK A DOCTOR BEFORE USE IF YOU HAVE
STOP USE AND ASK A DOCTOR IF
KEEP OUT OF REACH OF CHILDREN
DIRECTIONS
OTHER INFORMATION
QUESTIONS?
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
MUCUS RELIEF
guaifenesin tablet, extended release |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - McKesson Corporation dba SKY Packaging (140529962) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Guardian Drug Company | 119210276 | MANUFACTURE(63739-067) |
Revised: 11/2022
Document Id: b8593c77-a6de-4ace-b373-565df95f158d
Set id: 69b61f05-8f0b-420f-b4ef-df933b70eebc
Version: 2
Effective Time: 20221121